|
Q1 FY2023
As of Apr 3, 2022
|
Q4 FY2022
As of Jan 2, 2022
|
Q3 FY2022
As of Oct 3, 2021
|
Q2 FY2022
As of Jul 4, 2021
|
Q1 FY2022
As of Apr 4, 2021
|
|
|---|---|---|---|---|---|
| Assets | |||||
| Current assets: | |||||
| Cash and cash equivalents | |||||
| Accounts receivable (net of allowance for credit losses of $0.0 and $8.6, respectively) | |||||
| Inventories | |||||
| Other current assets | |||||
| Total current assets | |||||
| Property, plant and equipment, net | |||||
| Goodwill | |||||
| Intangible assets, net | |||||
| Deferred income taxes | |||||
| Other assets | |||||
| Total assets | |||||
| Liabilities and Shareholders’ Equity (Deficit) | |||||
| Current liabilities: | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Deferred revenue | |||||
| Current portion of borrowings | |||||
| Total current liabilities | |||||
| Long-term borrowings | |||||
| Employee-related obligations | |||||
| Other liabilities | |||||
| Deferred income taxes | |||||
| Total liabilities | |||||
| Shareholders' Equity: | |||||
| Preferred redeemable shares, $1.39 nominal value per share, 50,000 shares issued and outstanding as of April 3, 2022 and January 2, 2022, respectively | |||||
| Ordinary shares, $0.00001 par, 1,000,000,000 shares authorized, 0 and 237,203,879 shares issued and outstanding as of April 3, 2022 and January 2, 2022, respectively | |||||
| Additional paid-in capital | |||||
| Accumulated deficit | |||||
| Accumulated other comprehensive loss | |||||
| Total shareholders' equity | |||||
| Total liabilities and shareholders' equity |
Loading...
